About Proteocyte AI

Proteocyte AI is focused in the computational pathology sector, combing artificial intelligence and protein biomarkers to determine a patient’s 5-year risk of developing cancer. This is technology that predicts who is at risk to develop cancer before they actually have cancer.

Company Highlights
Year Founded

2011

icon-altEmployees

6

Location (HQ)

CAN

Since Last Funding

9 years 9 months

Monthly Website Visitors

2.3K

icon-altTotal Investment Amt

$600K

Last Funding Round

Seed

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Artificial Intelligence

Machine Learning

Medical

Health Care

Hospitals and Health Care

Collaboration

Hospitality